Alimera Sciences reported $34.01M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US USD 133.33M 13.67M
Alimera Sciences ALIM:US USD 34.01M 8.58M
Applied Genetic Technologies AGTC:US USD 26.6M 1.4M
Bayer BAYN:GR EUR 33.17B 471M
Insmed INSM:US USD 137.65M 23.84M
Novartis NOVN:VX USD 28.16B 514M
Ophthotech OPHT:US USD 24.59M 1.89M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M